193 related articles for article (PubMed ID: 32632941)
1. Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium.
Shanker MD; Liu HY; Lee YY; Stuart KA; Powell EE; Wigg A; Pryor DI
J Gastroenterol Hepatol; 2021 Apr; 36(4):873-884. PubMed ID: 32632941
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities.
Klein J; Dawson LA
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):22-32. PubMed ID: 23219567
[TBL] [Abstract][Full Text] [Related]
4. Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis.
Daniell KM; Banson KM; Diamond BH; Sioshansi S
Curr Treat Options Oncol; 2022 Dec; 23(12):1761-1774. PubMed ID: 36333623
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
[TBL] [Abstract][Full Text] [Related]
6. Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.
Chen LC; Chiou WY; Lin HY; Lee MS; Lo YC; Huang LW; Chang CM; Hung TH; Lin CW; Tseng KC; Liu DW; Hsu FC; Hung SK
BMC Cancer; 2019 Mar; 19(1):275. PubMed ID: 30922261
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
Schaub SK; Hartvigson PE; Lock MI; Høyer M; Brunner TB; Cardenes HR; Dawson LA; Kim EY; Mayr NA; Lo SS; Apisarnthanarax S
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790217. PubMed ID: 30068240
[TBL] [Abstract][Full Text] [Related]
9. SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.
Qiu H; Moravan MJ; Milano MT; Usuki KY; Katz AW
J Gastrointest Cancer; 2018 Dec; 49(4):463-469. PubMed ID: 28710606
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
[TBL] [Abstract][Full Text] [Related]
11. Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.
Lee YYD; Nguyen DT; Moodie T; O'Brien R; McMaster A; Hickey A; Pritchard N; Poulsen P; Tabaksblat EM; Weber B; Worm E; Pryor D; Chu J; Hardcastle N; Booth J; Gebski V; Wang T; Keall P
BMC Cancer; 2021 May; 21(1):494. PubMed ID: 33941111
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
J Gastroenterol Hepatol; 2020 Nov; 35(11):1953-1959. PubMed ID: 32052884
[TBL] [Abstract][Full Text] [Related]
14. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM
J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Choi SH; Seong J
Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
[TBL] [Abstract][Full Text] [Related]
16. Technical advances in external radiotherapy for hepatocellular carcinoma.
Park SH; Kim JC; Kang MK
World J Gastroenterol; 2016 Aug; 22(32):7311-21. PubMed ID: 27621577
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities.
Meyer J; Singal AG
Liver Transpl; 2018 Mar; 24(3):420-427. PubMed ID: 29205797
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes.
Shanker MD; Moodaley P; Soon W; Liu HY; Lee YY; Pryor DI
J Med Imaging Radiat Oncol; 2021 Dec; 65(7):956-968. PubMed ID: 34396706
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for hepatocellular carcinoma.
Feng M; Ben-Josef E
Semin Radiat Oncol; 2011 Oct; 21(4):271-7. PubMed ID: 21939856
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
McPartlin AJ; Dawson LA
Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]